Fluocinonide: profile and news
(PZ) Medicis Announces FDA Approval of Broader Indication for ... Mar 2, 2006
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - Houston Chronicle,
Medicis to Present at Merrill Lynch 17th Annual Global ... Feb 3, 2006
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - Genetic Engineering News,
Medicis Board Unanimously Rejects Mentor Proposal Nov 20, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - Business Wire (press release),
Medicis to Present at UBS Global Life Sciences Conference Sep 26, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - PharmaLive.com (press release),
Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds ... Sep 6, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - Business Wire (press release),
Medicis to Present at Banc of America Securities 2005 Specialty ... Jul 25, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - Business Wire (press release)
<**results**>
Medicis to Present at Thomas Weisel Partners Growth Forum 7.0 Jun 9, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - PharmaLive.com (press release),
Medicis Declares Cash Dividend Jun 15, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - Business Wire (press release),
Medicis Reports Third Quarter Fiscal 2005 Financial Results Apr 21, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - PharmaLive.com,
FDA Approvals: Vanos, Proxinium, INO-1001 Feb 17, 2005
17, 2005 — The US Food and Drug Administration (FDA) has approved fluocinonide 0.1% cream for the treatment of plaque-type psoriasis; orphan drug Proxinium ... - Medscape (subscription)
Medicis Announces FDA Approval of Its NDA for VANOS, a Patented ... Feb 14, 2005
VANOS(TM) provides physicians and patients with the established safety of fluocinonide and the potency of a Class I topical corticosteroid. ... - Business Wire (press release),
Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder Feb 18, 2005
HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05 ... - Business Wire (press release),
Medicis' psoriasis treatment gets FDA approval Feb 16, 2005
...in Canada, is a patented corticosteroid cream formulation for once or twice daily application which embodies the heritage of Lidex (fluocinonide), the sixth ... - Pharmaceutical Business Review
